Related Experiment Videos
Safety profile of cefprozil
R B Wilber1, C A Doyle, S J Durham
1Bristol-Myers Squibb, Pharmaceutical Research Institute, Wallingford, Connecticut 06492.
Summary
Cefprozil demonstrates a favorable safety profile in both adults and children across various infections. Clinical trial data show adverse events comparable to other oral cephalosporins, with lower diarrhea incidence.
Area of Science:
- Pharmacology
- Clinical Medicine
- Infectious Diseases
Background:
- Cefprozil is an oral cephalosporin antibiotic used for treating bacterial infections.
- Evaluating the safety of cefprozil in diverse patient populations and infection types is crucial for clinical practice.
Purpose of the Study:
- To comprehensively analyze the clinical and laboratory safety of cefprozil.
- To compare the safety of cefprozil with other oral cephalosporins.
Main Methods:
- Analysis of safety data from 4,227 patients in North American and European clinical efficacy trials.
- Inclusion of adult and pediatric patients treated with cefprozil capsules, tablets, or suspension.
- Assessment of cefprozil administered in once-daily or twice-daily dosing regimens for various infections.
Main Results:
- The incidence of adverse clinical events and laboratory abnormalities was similar to other oral cephalosporins.
- Gastrointestinal adverse effects were the most common clinical events.
- Cefprozil exhibited a significantly lower incidence of diarrhea compared to less-absorbed cephalosporins.
Conclusions:
- Cefprozil is confirmed as a safe antibiotic option for both adult and pediatric patients.
- The safety profile supports the use of cefprozil in treating common bacterial infections.